Traditionally, a drug that is loaded onto a metallic surface has to use various polymer bondings as its platform. Unfortunately, polymer coatings on a metallic surface cause numerous problems after implantation, such as late thrombosis, inflammation, and restenosis. This research was conducted to investigate whether an oxide layer can be used as a polymer-free platform for drug loading, especially for cardiovascular stents. The interaction and loading of heparin onto different oxide films on 316LVM stainless steel wire was confirmed in vitro by experimental studies using linear voltammetry, electrochemical impedance spectroscopy, and electron spectroscopy for chemical analysis. The eluting of heparin from heparinized surface was studied by using high-performance liquid chromatography, and activated clotting time in addition to linear voltammetry and electron spectroscopy for chemical analysis analyses. Experimental results show that amorphous oxide could be a potential substitute for the polymer coating of drug-loaded stents for minimizing metallic corrosion, inflammation, late thrombosis, and restenosis.

Original languageEnglish
Pages (from-to)519-529
Number of pages11
JournalJournal of Biomedical Materials Research - Part A
Issue number3
Publication statusPublished - Dec 2005


  • Amorphous oxide
  • Drug-loading
  • Heparin
  • Stainless steel

ASJC Scopus subject areas

  • Ceramics and Composites
  • Metals and Alloys
  • Biomedical Engineering
  • Biomaterials


Dive into the research topics of 'In vitro study of drug loading on polymer-free oxide films of metallic implants'. Together they form a unique fingerprint.

Cite this